Related Experiment Video
Updated: Jun 28, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
[Cholestasis and liver dysfunction in critical care patients]
M Kredel1, J Brederlau, N Roewer
1Klinik und Poliklinik für Anästhesiologie, Julius-Maximilians-Universität, Würzburg, Germany.
Der Anaesthesist
|November 8, 2008
Summary
Diagnosing liver dysfunction involves analyzing liver enzymes, bilirubin, and ammonia, alongside assessing metabolic capacity and excretory function. Treatment focuses on underlying causes and managing secondary complications, with liver support systems available for severe cases.
Area of Science:
- Hepatology and clinical biochemistry.
- Diagnostic imaging and interventional radiology.
Context:
- Liver function tests, including serum enzymes, bilirubin, ammonia, coagulation factors, albumin, and cholinesterase, are crucial for diagnosing liver dysfunction.
- Dynamic functional assessments and imaging techniques provide insights into hepatic metabolic activity, excretory function, liver structure, vascular supply, and biliary system.
- Various factors like high-pressure ventilation, parenteral nutrition, shock, hypoxia, and certain medications can precipitate cholestasis and liver dysfunction.
Purpose:
- To outline the comprehensive diagnostic strategies for liver function disturbances.
- To discuss the management principles for obstructive and non-obstructive cholestasis.
- To highlight the treatment of secondary organ dysfunctions and the role of liver support systems in liver failure.
Summary:
- Diagnostic evaluation of liver dysfunction relies on biochemical markers (enzymes, bilirubin, ammonia, albumin, coagulation factors) and dynamic functional assessments.
- Imaging modalities aid in visualizing liver morphology, vasculature, and the biliary tree, complementing biochemical data.
- Management strategies differentiate between obstructive and non-obstructive cholestasis, emphasizing treatment of the cause and secondary organ failures, with extracorporeal liver support as an option.
Impact:
- Provides a framework for understanding the multifaceted approach to diagnosing and managing liver dysfunction.
- Emphasizes the importance of addressing secondary complications and considering advanced therapies like MARS for liver failure.
- Aids clinicians in optimizing patient care by integrating biochemical, functional, and imaging data for accurate diagnosis and effective treatment planning.
Related Concept Videos
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...